Arquist 250 mikrograma po potisku, stlačeni inhalat, suspenzija
Name | Arquist 250 mikrograma po potisku, stlačeni inhalat, suspenzija |
---|---|
Former Name | Truflo 250 mikrograma/dozi, stlačeni inhalat, suspenzija |
Marketing Authorisation Number | HR-H-620322804 |
Active Substance | flutikazonpropionat |
Composition | jedna odmjerena doza sadrži 250 mikrograma flutikazonpropionata |
Pharmaceutical Form | stlačeni inhalat, suspenzija |
Manufacturer | S&D Pharma CZ, spol. s r.o, Pchery (Pharmos a.s. facility), Češka Cipla Europe NV, Antwerpen, Belgija Amring Farma S.R.L., Bukurešt, Rumunjska Glenmark Pharmaceuticals s.r.o., Vysoké Mýto, Češka |
Marketing Authorisation Holder | Cipla Europe NV, De Keyserlei 58-60, Box-19, Antwerpen, Belgija |
Marketing Authorisation Date | 13.08.2020 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/19-02/149 |
Registration Number | 381-12-01/70-20-02 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | R03BA05 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |